Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Dr Reddy

    Tag: dr reddy

    You Searched For "Dr Reddy"
    USFDA seeks voluntary action at Dr Reddys Duvvada facility

    USFDA seeks voluntary action at Dr Reddy's Duvvada facility

    Medical Dialogues Bureau17 Feb 2020 3:10 PM IST
    New Delhi: The US health regulator has asked drug major Dr Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra...
    Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore

    Dr Reddys Q2 revenue up 26.4 pc to Rs 4801 crore

    Medical Dialogues Bureau3 Nov 2019 9:30 AM IST
    Revenue in the second quarter stood at Rs 4,800.9 crore as against Rs 3,797.8 crore in the year-ago period, an increase of 26.41 per cent, Dr Reddy's...
    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Medical Dialogues Bureau24 Oct 2019 9:30 AM IST
    This recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
    Dr Reddys unveils generic version of Zyban ER tablets in US

    Dr Reddys unveils generic version of Zyban ER tablets in US

    Medical Dialogues Bureau5 Sept 2019 5:01 PM IST
    The company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu

    Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu

    Medical Dialogues Bureau20 July 2019 11:37 AM IST
    In a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
    Dr Reddys unveils generic version of Vitamin K1 injection in US

    Dr Reddys unveils generic version of Vitamin K1 injection in US

    Medical Dialogues Bureau25 Jun 2019 10:52 AM IST
    The Vitamin K1 (Phytonadione) for Injectable Emulsion USP, 10 mg/ml brand and generic, had combined US sales of approximately USD 46.6 million MAT for...
    Dr Reddys gets two USFDA observations for Vizag plants

    Dr Reddys gets two USFDA observations for Vizag plants

    Farhat Nasim24 Jun 2019 11:09 AM IST
    Hyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
    Dr Reddy

    Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction

    Farhat Nasim28 March 2019 12:06 PM IST
    Dr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
    USFDA completes audit for Dr Reddys Shreveport plant, no observations issued

    USFDA completes audit for Dr Reddys Shreveport plant, no observations issued

    Medical Dialogues Bureau23 Feb 2019 9:30 AM IST
    "The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
    Dr Reddy

    Dr Reddy's gets four observations from USFDA for Andhra plant

    Medical Dialogues Bureau19 Jan 2019 9:30 AM IST
    "The audit of our formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US Food and Drug Administration (USFDA), has been completed today....
    Dr Reddy

    Dr Reddy's gets nod to restart exports to EU from Vizag plant

    Ruby Khatun Khatun2 Dec 2017 10:30 AM IST
    New Delhi: Dr. Reddy's Laboratories said a German regulatory authority has allowed company's Visakhapatnam-based plant to restart production for the...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok